Australian Clinical Labs
ACL.AX
#8117
Rank
โ‚น24.25 B
Marketcap
โ‚น127.43
Share price
-3.48%
Change (1 day)
-20.22%
Change (1 year)

EPS for Australian Clinical Labs (ACL.AX)

EPS in 2024: โ‚น7.52

According to Australian Clinical Labs's latest financial reports the company's current EPS (TTM) is โ‚น7.52. In 2024 the company made an earnings per share (EPS) of โ‚น7.52 a decrease over its 2023 EPS that were of โ‚น11.17.

EPS history for Australian Clinical Labs from 2021 to 2024

Annual EPS

Year EPS Change
2024โ‚น7.52-32.69%
2023โ‚น11.17-80.47%
2022โ‚น57.20105.25%
2021โ‚น27.87